Milestone Pharmaceuticals (MIST) Short Interest Ratio & Short Volume → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free MIST Stock Alerts $1.75 -0.01 (-0.57%) (As of 04/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Milestone Pharmaceuticals Short Interest DataCurrent Short Volume559,500 sharesPrevious Short Volume480,100 sharesChange Vs. Previous Month+16.54%Dollar Volume Sold Short$1.00 millionShort Interest Ratio / Days to Cover1.6Last Record DateMarch 31, 2024Outstanding Shares53,150,000 sharesPercentage of Shares Shorted1.05%Today's Trading Volume112,672 sharesAverage Trading Volume210,380 sharesToday's Volume Vs. Average54% Short Selling Milestone Pharmaceuticals ? Sign up to receive the latest short interest report for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMIST Short Interest Over TimeMIST Days to Cover Over TimeMIST Percentage of Float Shorted Over Time Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Milestone Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024559,500 shares $1.00 million +16.5%N/A1.6 $1.79 3/15/2024480,100 shares $696,145.00 +6.4%N/A1.1 $1.45 2/29/2024451,300 shares $758,184.00 +19.8%N/A1.1 $1.68 2/15/2024376,700 shares $602,720.00 -7.1%N/A1.2 $1.60 1/31/2024405,300 shares $648,480.00 -0.1%N/A1.4 $1.60 1/15/2024405,600 shares $628,680.00 -14.9%N/A1.5 $1.55 Get the Latest News and Ratings for MIST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023476,800 shares $796,256.00 +27.7%N/A2 $1.67 12/15/2023373,300 shares $974,313.00 -4.2%N/A1.9 $2.61 11/30/2023389,500 shares $1.30 million +1.5%N/A3.2 $3.34 11/15/2023383,900 shares $871,453.00 +12.3%N/A4.1 $2.27 10/31/2023342,000 shares $875,520.00 -6.1%N/A4.6 $2.56 10/15/2023364,300 shares $1.06 million -9.3%N/A4 $2.90 9/30/2023401,600 shares $1.24 million -16.8%N/A4 $3.10 9/15/2023482,800 shares $1.52 million -6.3%N/A4 $3.15 8/31/2023515,300 shares $1.38 million -45.4%N/A4 $2.68 8/15/2023943,800 shares $3.02 million +4.4%N/A7.3 $3.20 7/31/2023904,400 shares $2.92 million -1.8%N/A7 $3.23 7/15/2023921,200 shares $3.24 million +5.3%N/A8.6 $3.52 6/30/2023875,200 shares $2.49 million -14.2%N/A8.2 $2.85 6/15/20231,020,000 shares $3.81 million No ChangeN/A9.3 $3.74 5/31/20231,020,000 shares $4.02 million No ChangeN/A9.7 $3.94 5/15/20231,020,000 shares $4.29 million -2.9%N/A9 $4.21 4/30/20231,050,000 shares $3.81 million +4.0%N/A8.6 $3.63 4/15/20231,010,000 shares $3.63 million +5.2%3.4%6.7 $3.59 3/31/2023960,000 shares $3.78 million -0.6%N/A5.7 $3.94 3/15/2023966,100 shares $3.41 million +5.2%N/A6 $3.53 2/28/2023918,200 shares $2.90 million -0.2%N/A4.2 $3.16 2/15/2023919,700 shares $3.26 million +2.7%N/A4.1 $3.54 1/31/2023895,800 shares $3.28 million -0.9%3.1%3 $3.66 1/15/2023903,800 shares $3.55 million -8.9%3.1%2.1 $3.93 12/30/2022992,000 shares $3.93 million +1.3%3.4%1.5 $3.96 12/15/2022979,300 shares $3.72 million +13.4%3.4%1.5 $3.80 11/30/2022863,300 shares $4.24 million -2.1%3.0%1.3 $4.91 11/15/2022881,900 shares $3.86 million +0.4%3.1%1.3 $4.38 10/31/2022878,300 shares $4.41 million +9.1%4.0%1.3 $5.02 10/15/2022805,200 shares $6.84 million -4.7%4.3%1.4 $8.49 9/30/2022845,000 shares $7.77 million +2.1%4.5%3 $9.19 9/15/2022827,600 shares $7.57 million +9.7%4.5%3.6 $9.15 8/31/2022754,500 shares $6.53 million +4.3%3.7%4.3 $8.66 8/15/2022723,300 shares $5.14 million +102.6%3.5%7.1 $7.10The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! MIST Short Interest - Frequently Asked Questions What is Milestone Pharmaceuticals' current short interest? Short interest is the volume of Milestone Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 559,500 shares of MIST short. Learn More on Milestone Pharmaceuticals' current short interest. What is a good short interest ratio for Milestone Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MIST shares currently have a short interest ratio of 2.0. Learn More on Milestone Pharmaceuticals's short interest ratio. Which institutional investors are shorting Milestone Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Milestone Pharmaceuticals: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Milestone Pharmaceuticals' short interest increasing or decreasing? Milestone Pharmaceuticals saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 559,500 shares, an increase of 16.5% from the previous total of 480,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Milestone Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Milestone Pharmaceuticals: Connect Biopharma Holdings Limited (0.22%), Reviva Pharmaceuticals Holdings, Inc. (3.80%), Genelux Co. (9.50%), Allakos Inc. (6.33%), Seres Therapeutics, Inc. (12.45%), DiaMedica Therapeutics Inc. (0.53%), Oramed Pharmaceuticals Inc. (1.44%), Barinthus Biotherapeutics plc (0.03%), Aclaris Therapeutics, Inc. (6.89%), Anixa Biosciences, Inc. (1.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Milestone Pharmaceuticals stock? Short selling MIST is an investing strategy that aims to generate trading profit from Milestone Pharmaceuticals as its price is falling. MIST shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Milestone Pharmaceuticals? A short squeeze for Milestone Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MIST, which in turn drives the price of the stock up even further. How often is Milestone Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MIST, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Connect Biopharma Short Interest Reviva Pharmaceuticals Short Interest Genelux Short Interest Allakos Short Interest Seres Therapeutics Short Interest DiaMedica Therapeutics Short Interest Oramed Pharmaceuticals Short Interest Barinthus Biotherapeutics Short Interest Aclaris Therapeutics Short Interest Anixa Biosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MIST) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profits[Urgent!] Generational Wealth GameplanCrypto 101 MediaTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBiden out June 13; Kamala won’t replace him?Paradigm PressUrgent alert: open this for a huge profit potentialTimothy SykesOptions trading has suddenly become more reliable.Eagle PublishingThe Greatest Bull Market in Crypto History…Weiss Ratings